Immucor to increase volume of shares:
This article was originally published in Clinica
Immucor's existing shareholders are to receive a 50% stock dividend following the company's decision to go ahead with a 3-for-2 stock split. The move will increase the number of shares of common stock outstanding from over 20 million, as recorded at the end of May, to over 30 million. The expected date of distribution is July 16. Since received FDA approval for its fully automated Galileo blood sample analyser in April, the company saw its share price go up nearly 27%. According to the Norcross, Georgia-based company, the aim in increasing the number of shares is to make the price of its stock more accessible to investors of all levels. This is the sixth stock split for Immucor since its IPO in December 1985.